| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 09/26/1996 | CA2215618A1 Protein production and delivery |
| 09/26/1996 | CA2215162A1 Vectors for gene delivery |
| 09/26/1996 | CA2215122A1 Il-13 receptor specific chimeric proteins and uses thereof |
| 09/26/1996 | CA2215104A1 Compounds and methods for the detection of t. cruzi infection |
| 09/26/1996 | CA2214385A1 Cell culture method |
| 09/26/1996 | CA2211448A1 Rage tumor rejection antigens |
| 09/25/1996 | EP0733705A1 Hormone receptor compositions and methods |
| 09/25/1996 | EP0733123A1 Method for detection of methylthioadenosine phosphorylase deficiency in mammalian cells |
| 09/25/1996 | EP0733116A1 Method of controlling plant pathogens |
| 09/25/1996 | EP0733111A1 IFN-$g(g)RECEPTOR $g(b)-CHAIN AND DERIVATIVES THEREOF |
| 09/25/1996 | EP0733110A1 Tuberous sclerosis 2 gene and uses thereof |
| 09/25/1996 | EP0733109A1 Bmp-12, bmp-13 and tendon-inducing compositions thereof |
| 09/25/1996 | EP0733107A1 C5a RECEPTOR ANTAGONISTS HAVING SUBSTANTIALLY NO AGONIST ACTIVITY |
| 09/25/1996 | EP0733106A1 Plant arabinogalactan protein (agp) genes |
| 09/25/1996 | EP0733103A1 Generation of high titers of recombinant aav vectors |
| 09/25/1996 | EP0733102A1 Reagents and methods for the detection of methotrexate |
| 09/25/1996 | EP0733101A1 Glucose responsive insulin secreting beta-cell lines and method for producing same |
| 09/25/1996 | EP0733100A1 Chemical process for promoting the proliferation of animal cells |
| 09/25/1996 | EP0733059A1 Compounds and methods for site-directed mutations in eukaryotic cells |
| 09/25/1996 | EP0732941A1 Modulation of vascular cell adhesion molecule expression through novel oligonucleotide interactions |
| 09/25/1996 | EP0732940A1 Inhibition of extracellular matrix synthesis by antisense compounds directed to nuclear proto-oncogenes |
| 09/25/1996 | EP0732931A1 Methods for tissue embedding and tissue culturing |
| 09/25/1996 | EP0732930A1 Compositions which inhibit apoptosis, methods of purifying the compositions and uses thereof |
| 09/25/1996 | EP0732915A1 Local delivery of fibrinolysis enhancing agents |
| 09/25/1996 | EP0732875A1 Methods of modifying feeding behavior, compounds useful in such methods, and dna encoding a hypothalamic atypical neuropeptide y/peptide yy receptor (y5) |
| 09/25/1996 | EP0675726A4 Megakaryocyte and platelet growth, production and composition. |
| 09/25/1996 | EP0432249B1 Monoclonal antibodies against leukocyte adhesion receptor beta-chain, methods of producing these antibodies and use therefore |
| 09/25/1996 | CN1131950A Recombinant C140 receptor and its agonists and antagonists |
| 09/24/1996 | US5559250 Treating red blood cell solutions with anti-viral agents |
| 09/24/1996 | US5559027 Synergistic |
| 09/24/1996 | US5559022 Liver reserve cells |
| 09/24/1996 | US5558997 Monoclonal antibodies to mycosphaerella species |
| 09/24/1996 | US5558995 Peptides which are derived from tumor rejection antigen precursor molecule MAGE-1, which complex to MHC molecule HLA-C clone 10, and uses thereof |
| 09/24/1996 | US5558864 Humanized and chimeric anti-epidermal growth factor receptor monoclonal antibodies |
| 09/24/1996 | US5558861 Modified microbially-produced cellulose gel with human epidermal cells adsorbed thereon for use as a skin graft or vulnerary cover |
| 09/19/1996 | WO1996028564A1 Novel recombinant dna vectors for gene therapy |
| 09/19/1996 | WO1996028561A1 Chimeric genes comprising a fungus-responsive element |
| 09/19/1996 | WO1996028555A1 Novel human cyclin-dependent kinase-like proteins and methods of using the same |
| 09/19/1996 | WO1996028548A1 Receptor activation by gas6 |
| 09/19/1996 | WO1996028546A1 Human tumor necrosis factor receptor |
| 09/19/1996 | WO1996028541A1 Method for in vitro preconditioning of myoblasts before transplantation |
| 09/19/1996 | WO1996028539A1 Mesenchymal stem cells for cartilage repair |
| 09/19/1996 | WO1996028461A1 ISOLATED NUCLEIC ACID MOLECULES WHICH ARE MEMBERS OF THE MAGE-Xp FAMILY AND USES THEREOF |
| 09/19/1996 | WO1996028184A1 Lymphoblastoid natural interferon alpha production |
| 09/19/1996 | WO1996028174A1 Sertoli cells as transplantation facilitator for cell transplantation |
| 09/19/1996 | WO1996028029A1 Immunoisolation |
| 09/19/1996 | WO1996028014A1 Lycopene cyclase gene |
| 09/19/1996 | WO1996017936A3 Cloned porphyromonas gingivalis genes and probes for the detection of periodontal disease |
| 09/19/1996 | DE4090006C2 Purified sciatic nerve ciliary neurotrophic factor |
| 09/19/1996 | DE19532906A1 Neue, definierte Enzymmischungen zur Zellgewinnung und für die Wundbehandlung New, defined mixtures of enzymes for cell recovery and for the treatment of wounds |
| 09/19/1996 | CA2215039A1 Immunoisolation |
| 09/19/1996 | CA2215016A1 Isolated nucleic acid molecules which are members of the mage-xp family and uses thereof |
| 09/19/1996 | CA2214469A1 Lycopene cyclase gene |
| 09/19/1996 | CA2189361A1 Chimeric genes comprising a fungus-responsive element |
| 09/18/1996 | EP0732402A2 Chimeric chains for receptor-associated signal transduction pathways |
| 09/18/1996 | EP0732397A2 Modified hepatocytes and uses therefor |
| 09/18/1996 | EP0732340A2 Expression of porcine reproductive respiratory syndrome virus polypeptides in the same cell |
| 09/18/1996 | EP0732104A1 Useful composition for the manufacture of vaccines containing particles bearing a hepatitis B virus surface antigen and polymerized human seric albumin receptor, animal cells able to produce such particles and process for their obtention |
| 09/18/1996 | EP0731845A1 Homologous recombination antibody expression system for murine cells |
| 09/18/1996 | EP0731839A1 Vector, viral protein, nucleotide sequence coding therefor and method for inhibiting immune recognition |
| 09/18/1996 | EP0731838A1 Binding structures directed against the ca55.1 antigen |
| 09/18/1996 | EP0731806A1 SPECIFIC FUSION NUCLEIC ACIDS AND PROTEINS PRESENT IN HUMAN t(2;5) LYMPHOMA, METHODS OF DETECTION AND USES THEREOF |
| 09/18/1996 | EP0731636A1 Novel apoptosis-modulating proteins, dna encoding the proteins and methods of use thereof |
| 09/18/1996 | EP0731632A1 $i(AGROBACTERIUM TUMEFACIENS) TRANSFORMATION OF $i(MUSA) SPECIES |
| 09/18/1996 | EP0593625B1 Short-term anti-cd3 stimulation of lymphocytes to increase their in vivo activity |
| 09/18/1996 | EP0524958B1 Antigenic proteins of borrelia burgdorferi |
| 09/18/1996 | CN1131439A Chitinase DNA coding thereof and plants containing same |
| 09/18/1996 | CN1131437A Antisense oligonucleotide inhibition of vascular endothelial growth factor expression |
| 09/17/1996 | US5556947 Monoclonal antibody recognizing a surface molecule on a subset of antigen-stimulated T cells and on certain malignancies of T and B cell origin |
| 09/17/1996 | US5556783 Methods of culturing and modulating the growth of hair follicular stem cells |
| 09/17/1996 | US5556770 Hybridoma growth, lipopolysaccharides |
| 09/17/1996 | US5556763 Patterns of transcription factors and lymphocytes |
| 09/17/1996 | US5556757 Peptides representing epitopic sites for bacterial and viral meningitis causing agents and their CNS carrier and uses thereof |
| 09/17/1996 | US5556753 DNA encoding human α1 adrenegric receptors and uses thereof |
| 09/17/1996 | CA2144997A1 Method of growing tumour cells for cytogenetic analysis |
| 09/12/1996 | WO1996027674A1 Modified starch from plants, plants synthesizing this starch, and process for its preparation |
| 09/12/1996 | WO1996027673A1 Control of gene expression in plants by receptor mediated transactivation in the presence of a chemical ligand |
| 09/12/1996 | WO1996027662A1 Novel encapsulation process by a gelling polymer |
| 09/12/1996 | WO1996027658A1 Stimulation of meiosis |
| 09/12/1996 | WO1996027657A1 Cell growth substrates with tethered cell growth effector molecules |
| 09/12/1996 | WO1996027610A1 Nucleotide and protein sequences of vertebrate serrate genes and methods based thereon |
| 09/12/1996 | WO1996027603A1 Compositions and methods for the treatment and diagnosis of immune disorders |
| 09/12/1996 | WO1996027420A1 Method for enriching rare cell population |
| 09/12/1996 | WO1996027392A1 Antigen presenting system and methods for activation of t-cells |
| 09/12/1996 | WO1996027388A1 Stabilized compositions containing hemoglobin |
| 09/12/1996 | WO1996027367A1 Novel encapsulation compositions and methods |
| 09/12/1996 | WO1996027287A1 Cryopreservation solution |
| 09/12/1996 | WO1996022380A3 Method to improve screening efficiency in fused cells |
| 09/12/1996 | WO1996021022A3 Production of gamma linolenic acid by a δ6-desaturase |
| 09/12/1996 | WO1996012794A3 Isolated porcine pancreatic cells for use in treatment of diseases characterized by insufficient insulin activity |
| 09/12/1996 | DE19509695A1 Verfahren zur Herstellung einer modifizieren Stärke in Pflanzen, sowie die aus den Pflanzen isolierbare modifizierte Stärke A process for producing a modified starch in plants, and the plants can be isolated from the modified starch |
| 09/12/1996 | CA2214736A1 Modified starch from plants, plants synthesizing the same, as well as process for their production |
| 09/12/1996 | CA2214589A1 Compositions and methods for the treatment and diagnosis of immune disorders |
| 09/12/1996 | CA2214126A1 Stimulation of meiosis |
| 09/12/1996 | CA2214088A1 Novel encapsulation process by a gelling polymer |
| 09/12/1996 | CA2214084A1 Novel encapsulation compositions and methods |
| 09/11/1996 | EP0731170A1 Insect-resistant plants |
| 09/11/1996 | EP0731169A1 Vectors and use thereof for capturing target genes |
| 09/11/1996 | EP0731165A2 Human T-cell line infected with HIV-2 which secretes functionally intact HIV-2 GP160 |
| 09/11/1996 | EP0731163A2 Culture skin and process for preparing the same |